Corcept Therapeutics Inc
CORT· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $5.85M | $1.89M | $875.00K | — |
| Net Income | -$7.55M | -$11.90M | -$7.60M | -$8.88M |
| EPS Diluted | -$0.07 |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| -$0.12 |
| -$0.09 |
| -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.